Cargando…

Comparison of Proteomic Technologies for Blood-Based Detection of Colorectal Cancer

Blood-based protein biomarkers are increasingly being explored as supplementary or efficient alternatives for population-based screening of colorectal cancer (CRC). The objective of the current study was to compare the diagnostic potential of proteins measured with different proteomic technologies....

Descripción completa

Detalles Bibliográficos
Autores principales:	Bhardwaj, Megha, Terzer, Tobias, Schrotz-King, Petra, Brenner, Hermann
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865621/ https://www.ncbi.nlm.nih.gov/pubmed/33530402 http://dx.doi.org/10.3390/ijms22031189

Ejemplares similares

Cell Line Secretome and Tumor Tissue Proteome Markers for Early Detection of Colorectal Cancer: A Systematic Review
por: Bhardwaj, Megha, et al.
Publicado: (2017)

Blood-Based Protein Signatures for Early Detection of Colorectal Cancer: A Systematic Review
por: Bhardwaj, Megha, et al.
Publicado: (2017)

Metabolomics Biomarkers for Detection of Colorectal Neoplasms: A Systematic Review
por: Erben, Vanessa, et al.
Publicado: (2018)

Correlation of Repeat Measurements of 27 Candidate Protein Markers for Colorectal Cancer Screening Taken Three Years and Multiple Freeze–Thaw Cycles Apart
por: Bhardwaj, Megha, et al.
Publicado: (2022)

Multiplex screening of 275 plasma protein biomarkers to identify a signature for early detection of colorectal cancer
por: Bhardwaj, Megha, et al.
Publicado: (2019)

Assessment of a Serum Microrna Risk Score for Colorectal Cancer among Participants of Screening Colonoscopy at Various Stages of Colorectal Carcinogenesis
por: Raut, Janhavi R., et al.
Publicado: (2022)

Fecal microRNAs, Fecal microRNA Panels, or Combinations of Fecal microRNAs with Fecal Hemoglobin for Early Detection of Colorectal Cancer and Its Precursors: A Systematic Review
por: Zhao, Zitong, et al.
Publicado: (2021)

Evaluation and Validation of Plasma Proteins Using Two Different Protein Detection Methods for Early Detection of Colorectal Cancer
por: Bhardwaj, Megha, et al.
Publicado: (2019)

Direct comparison of ten quantitative fecal immunochemical tests for hemoglobin stability in colorectal cancer screening
por: Gies, Anton, et al.
Publicado: (2018)

A microRNA panel compared to environmental and polygenic scores for colorectal cancer risk prediction
por: Raut, Janhavi R., et al.
Publicado: (2021)

Whole-blood DNA Methylation Markers for Risk Stratification in Colorectal Cancer Screening: A Systematic Review
por: Raut, Janhavi R., et al.
Publicado: (2019)

Potential of Inflammatory Protein Signatures for Enhanced Selection of People for Lung Cancer Screening
por: Bhardwaj, Megha, et al.
Publicado: (2022)

Fecal DNA methylation markers for detecting stages of colorectal cancer and its precursors: a systematic review
por: Raut, Janhavi R., et al.
Publicado: (2020)

Fecal Immunochemical Tests Detect Screening Participants with Multiple Advanced Adenomas Better than T1 Colorectal Cancers
por: Gies, Anton, et al.
Publicado: (2021)

Vitamin D Status, Cdx2 Genotype, and Colorectal Cancer Survival: Population-Based Patient Cohort
por: Gwenzi, Tafirenyika, et al.
Publicado: (2023)

Combination of Different Fecal Immunochemical Tests in Colorectal Cancer Screening: Any Gain in Diagnostic Performance?
por: Gies, Anton, et al.
Publicado: (2019)

Comparing Metabolomics Profiles in Various Types of Liquid Biopsies among Screening Participants with and without Advanced Colorectal Neoplasms
por: Erben, Vanessa, et al.
Publicado: (2021)

A serum microRNA signature for enhanced selection of people for lung cancer screening
por: Yu, Haixin, et al.
Publicado: (2022)

Prognostic Value of Post-Operative C-Reactive Protein-Based Inflammatory Biomarkers in Colorectal Cancer Patients: Systematic Review and Meta-Analysis
por: Gwenzi, Tafirenyika, et al.
Publicado: (2023)

Effects of Alternative Offers of Screening Sigmoidoscopy and Colonoscopy on Utilization and Yield of Endoscopic Screening for Colorectal Neoplasms: Protocol of the DARIO Randomized Trial
por: Schrotz-King, Petra, et al.
Publicado: (2020)

Consistent Major Differences in Sex- and Age-Specific Diagnostic Performance among Nine Faecal Immunochemical Tests Used for Colorectal Cancer Screening
por: Gies, Anton, et al.
Publicado: (2021)

Evaluation of different stool extraction methods for metabolomics measurements in human faecal samples
por: Erben, Vanessa, et al.
Publicado: (2021)

Fecal occult blood versus DNA testing: indirect comparison in a colorectal cancer screening population
por: Brenner, Hermann, et al.
Publicado: (2017)

Robust prediction of gene regulation in colorectal cancer tissues from DNA methylation profiles
por: Klett, Hagen, et al.
Publicado: (2018)

Stage-Specific Sensitivity of Fecal Immunochemical Tests for Detecting Colorectal Cancer: Systematic Review and Meta-Analysis
por: Niedermaier, Tobias, et al.
Publicado: (2020)

Association of the inflammation-related proteome with dementia development at older age: results from a large, prospective, population-based cohort study
por: Trares, Kira, et al.
Publicado: (2022)

Enhanced selection of people for lung cancer screening using AHRR (cg05575921) or F2RL3 (cg03636183) methylation as biological markers of smoking exposure
por: Bhardwaj, Megha, et al.
Publicado: (2023)

Development and validation of a panel of five proteins as blood biomarkers for early detection of colorectal cancer
por: Chen, Hongda, et al.
Publicado: (2017)

Minimally Invasive Colorectal Cancer Surgery in Europe: Implementation and Outcomes
por: Babaei, Masoud, et al.
Publicado: (2016)

Fecal Immunochemical Tests Combined With Other Stool Tests for Colorectal Cancer and Advanced Adenoma Detection: A Systematic Review
por: Niedermaier, Tobias, et al.
Publicado: (2016)

Comparison and combination of blood-based inflammatory markers with faecal occult blood tests for non-invasive colorectal cancer screening
por: Tao, S, et al.
Publicado: (2012)

Survival of patients with symptom- and screening-detected colorectal cancer
por: Brenner, Hermann, et al.
Publicado: (2016)

Identification and Evaluation of Plasma MicroRNAs for Early Detection of Colorectal Cancer
por: Luo, Xiaoya, et al.
Publicado: (2013)

Repeat physical activity measurement by accelerometry among colorectal cancer patients—feasibility and minimal number of days of monitoring
por: Skender, Stephanie, et al.
Publicado: (2015)

The Role of CT-Quantified Body Composition on Longitudinal Health-Related Quality of Life in Colorectal Cancer Patients: The Colocare Study
por: Gigic, Biljana, et al.
Publicado: (2020)

Flexible sigmoidoscopy in colorectal cancer screening: implications of different colonoscopy referral strategies
por: Niedermaier, Tobias, et al.
Publicado: (2018)

Epigenome-wide discovery and evaluation of leukocyte DNA methylation markers for the detection of colorectal cancer in a screening setting
por: Heiss, Jonathan Alexander, et al.
Publicado: (2017)

Potential of fecal microbiota for early-stage detection of colorectal cancer
por: Zeller, Georg, et al.
Publicado: (2014)

Head-to-Head Comparison of Family History of Colorectal Cancer and a Genetic Risk Score for Colorectal Cancer Risk Stratification
por: Weigl, Korbinian, et al.
Publicado: (2019)

Reproductive Factors and Colorectal Cancer Risk: A Population-Based Case-Control Study
por: Amitay, Efrat L, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_896t56c0ojomd2160iq39i0m8k